Results: 1-16 |
Results: 16
ADMINISTRATION OF PENTOSAN POLYSULFATE TO PATIENTS (PTS) WITH HIV-ASSOCIATED KAPOSIS-SARCOMA (KS)
Authors: PLUDA JM SHAY LE FOLI A COHEN PJ ADAMO D BRODER S YARCHOAN R
Citation: Jm. Pluda et al., ADMINISTRATION OF PENTOSAN POLYSULFATE TO PATIENTS (PTS) WITH HIV-ASSOCIATED KAPOSIS-SARCOMA (KS), Journal of acquired immune deficiency syndromes, 6(6), 1993, pp. 713-713
ADMINISTRATION OF PENTOSAN POLYSULFATE TO PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED KAPOSI-SARCOMA
Authors: PLUDA JM SHAY LE FOLI A TANNENBAUM S COHEN PJ GOLDSPIEL BR ADAMO D COOPER MR BRODER S YARCHOAN R
Citation: Jm. Pluda et al., ADMINISTRATION OF PENTOSAN POLYSULFATE TO PATIENTS WITH HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED KAPOSI-SARCOMA, Journal of the National Cancer Institute, 85(19), 1993, pp. 1585-1592
APPROACHES TO THE DEVELOPMENT OF THERAPY FOR KAPOSISS SARCOMA (KS) - A REPORT ON ONGOING STUDIES
Authors: YARCHOAN R SAVILLE MW PLUDA JM FOLI A BAILEY J WILSON W BRODER S
Citation: R. Yarchoan et al., APPROACHES TO THE DEVELOPMENT OF THERAPY FOR KAPOSISS SARCOMA (KS) - A REPORT ON ONGOING STUDIES, AIDS research and human retroviruses, 10, 1994, pp. 190000052-190000052
COMBINATION OF A DRUG TARGETING THE CELL WITH A DRUG TARGETING THE VIRUS CONTROLS HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RESISTANCE
Authors: LORI F MALYKH AG FOLI A MASERATI R DEANTONI A MINOLI L PADRINI DA DEGLIANTONI A BARCHI E JESSEN H WAINBERG MA GALLO RC LISZIEWICZ J
Citation: F. Lori et al., COMBINATION OF A DRUG TARGETING THE CELL WITH A DRUG TARGETING THE VIRUS CONTROLS HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 RESISTANCE, AIDS research and human retroviruses, 13(16), 1997, pp. 1403-1409
EFFECTS OF HUMAN-IMMUNODEFICIENCY-VIRUS AND COLONY-STIMULATING FACTORS ON THE PRODUCTION OF INTERLEUKIN-6 AND TUMOR-NECROSIS-FACTOR-ALPHA BY MONOCYTE MACROPHAGES/
Authors: FOLI A SAVILLE MW MAY LT WEBB DSA YARCHOAN R
Citation: A. Foli et al., EFFECTS OF HUMAN-IMMUNODEFICIENCY-VIRUS AND COLONY-STIMULATING FACTORS ON THE PRODUCTION OF INTERLEUKIN-6 AND TUMOR-NECROSIS-FACTOR-ALPHA BY MONOCYTE MACROPHAGES/, AIDS research and human retroviruses, 13(10), 1997, pp. 829-839
INHIBITION OF HIV REPLICATION IN MONOCYTE MACROPHAGES (M/M) BY INTERLEUKIN-10/
Authors: SAVILLE MW TOSATO G TAGA K FOLI A BRODER S YARCHOAN R
Citation: Mw. Saville et al., INHIBITION OF HIV REPLICATION IN MONOCYTE MACROPHAGES (M/M) BY INTERLEUKIN-10/, AIDS research and human retroviruses, 10, 1994, pp. 190000027-190000027
INTERLEUKIN-10 SUPPRESSES HUMAN IMMUNODEFICIENCY VIRUS-1 REPLICATION IN-VITRO IN CELLS OF THE MONOCYTE MACROPHAGE LINEAGE/
Authors: SAVILLE MW TAGA K FOLI A BRODER S TOSATO G YARCHOAN R
Citation: Mw. Saville et al., INTERLEUKIN-10 SUPPRESSES HUMAN IMMUNODEFICIENCY VIRUS-1 REPLICATION IN-VITRO IN CELLS OF THE MONOCYTE MACROPHAGE LINEAGE/, Blood, 83(12), 1994, pp. 3591-3599
INVITRO ACTIVITY OF TNP-470, A NOVEL ANGIOGENESIS INHIBITOR IN KAPOSI-SARCOMA (KS)-RELATED SPINDLE CELL-LINES
Authors: SAVILLE MW FOLI A BRODER S YARCHOAN R
Citation: Mw. Saville et al., INVITRO ACTIVITY OF TNP-470, A NOVEL ANGIOGENESIS INHIBITOR IN KAPOSI-SARCOMA (KS)-RELATED SPINDLE CELL-LINES, Journal of cellular biochemistry, 1993, pp. 22-22
IN-VITRO SELECTION AND MOLECULAR CHARACTERIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITH REDUCED SENSITIVITY TO 9-[2-(PHOSPHONOMETHOXY)ETHYL]ADENINE (PMEA)
Authors: FOLI A SOGOCIO KM ANDERSON B KAVLICK M SAVILLE MW WAINBERG MA GU ZX CHERRINGTON JM MITSUYA H YARCHOAN R
Citation: A. Foli et al., IN-VITRO SELECTION AND MOLECULAR CHARACTERIZATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 WITH REDUCED SENSITIVITY TO 9-[2-(PHOSPHONOMETHOXY)ETHYL]ADENINE (PMEA), Antiviral research, 32(2), 1996, pp. 91-98
K65R MUTATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE ENCODES CROSS-RESISTANCE TO 9-(2-PHOSPHONYLMETHOXYETHYL)ADENINE
Authors: GU ZX SALOMON H CHERRINGTON JM MULATO AS CHEN MS YARCHOAN R FOLI A SOGOCIO KM WAINBERG MA
Citation: Zx. Gu et al., K65R MUTATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REVERSE-TRANSCRIPTASE ENCODES CROSS-RESISTANCE TO 9-(2-PHOSPHONYLMETHOXYETHYL)ADENINE, Antimicrobial agents and chemotherapy, 39(8), 1995, pp. 1888-1891
LONG-TERM SUPPRESSION OF HIV-1 BY HYDROXYUREA AND DIDANOSINE
Authors: LORI F JESSEN H FOLI A LISZIEWICZ J
Citation: F. Lori et al., LONG-TERM SUPPRESSION OF HIV-1 BY HYDROXYUREA AND DIDANOSINE, JAMA, the journal of the American Medical Association, 277(18), 1997, pp. 1437-1438
MECHANISMS FOR THE OVERPRODUCTION OF INTERLEUKIN-6 (IL-6) AND TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) IN HIV-INFECTION
Authors: FOLI A SAVILLE MW YARCHOAN R
Citation: A. Foli et al., MECHANISMS FOR THE OVERPRODUCTION OF INTERLEUKIN-6 (IL-6) AND TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) IN HIV-INFECTION, AIDS research and human retroviruses, 10, 1994, pp. 190000075-190000075
MONOCYTE-MACROPHAGES (M M) PRODUCE INTERLEUKIN-6 (IL-6) AND TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) IN RESPONSE TO GRANULOCYTE MACROPHAGE-COLONY-STIMULATING FACTOR (GM-CSF), BUT NOT TO HIV-INFECTION ALONE/
Authors: FOLI A YARCHOAN R
Citation: A. Foli et R. Yarchoan, MONOCYTE-MACROPHAGES (M M) PRODUCE INTERLEUKIN-6 (IL-6) AND TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA) IN RESPONSE TO GRANULOCYTE MACROPHAGE-COLONY-STIMULATING FACTOR (GM-CSF), BUT NOT TO HIV-INFECTION ALONE/, Journal of acquired immune deficiency syndromes, 6(6), 1993, pp. 736-736
MUTATIONS IN THE POL GENE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN INFECTED PATIENTS RECEIVING DIDANOSINE AND HYDROXYUREA COMBINATION THERAPY
Authors: DEANTONI A FOLI A LISZIEWICZ J LORI F
Citation: A. Deantoni et al., MUTATIONS IN THE POL GENE OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN INFECTED PATIENTS RECEIVING DIDANOSINE AND HYDROXYUREA COMBINATION THERAPY, The Journal of infectious diseases, 176(4), 1997, pp. 899-903
PHASE I II STUDY OF INTERMITTENT ALL-TRANS-RETINOIC ACID, ALONE AND IN COMBINATION WITH INTERFERON ALFA-2A, IN PATIENTS WITH EPIDEMIC KAPOSIS-SARCOMA/
Authors: BAILEY J PLUDA JM FOLI A SAVILLE MW BAUZA S ADAMSON PC MURPHY RF COHEN RB BRODER S YARCHOAN R
Citation: J. Bailey et al., PHASE I II STUDY OF INTERMITTENT ALL-TRANS-RETINOIC ACID, ALONE AND IN COMBINATION WITH INTERFERON ALFA-2A, IN PATIENTS WITH EPIDEMIC KAPOSIS-SARCOMA/, Journal of clinical oncology, 13(8), 1995, pp. 1966-1974
THERAPEUTIC ADVANTAGE OF HYDROXYUREA AND DIDANOSINE COMBINATION THERAPY IN PATIENTS PREVIOUSLY TREATED WITH ZIDOVUDINE
Authors: FOLI A MASERATI R MINOLI L WAINBERG MA GALLO RC LISZIEWICZ J LORI F
Citation: A. Foli et al., THERAPEUTIC ADVANTAGE OF HYDROXYUREA AND DIDANOSINE COMBINATION THERAPY IN PATIENTS PREVIOUSLY TREATED WITH ZIDOVUDINE, AIDS, 12(9), 1998, pp. 1113-1114
Risultati: 1-16 |